ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2025
Contemporary strategies for repeat ablation of atrial fibrillation: a European Heart Rhythm Association survey.
Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Ethanol infusion of the vein of marshall-based strategies for persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026Pooled it
- Circulating miR-10b-5p as a candidate biomarker of atrial fibrillation recurrence after catheter ablation: a two-phase translational study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026Article
- Shortest pulmonary vein atrial fibrillation cycle length identifies pulmonary vein isolation responders beyond clinical atrial fibrillation pattern: the FARS-AF II study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsPulmonary vein isolation (PVI) is the cornerstone of atrial fibrillation (AF) ablation. However, the optimal strategy during repeat ablation is not clear. This European Heart Rhythm Association (EHRA) survey aims to assess real-world ablation strategies in patients undergoing repeat AF ablation. METHODS AND
resultsA 25-item questionnaire was distributed among healthcare professionals via EHRA between 22 May and 21 June 2024. Of the 211 respondents from 43 countries, 58.1% of respondents planned a redo after multiple symptomatic recurrences of atrial arrhythmias. Most repeat procedures (68.0%) are performed within 3 months after the decision for re-intervention. 3D mapping and radiofrequency (RF) catheters with contact force (CF) sensing are the most common modality used for repeat ablation. In patients with more than one pulmonary vein (PV) reconnection, most commonly reisolation of the PVs plus individualized substrate-based ablation is performed (62.2%). When empirical ablation is performed, the most common targets include cavotricuspid isthmus (22.5%), posterior wall isolation (20.7%), left atrial roofline (16.1%), anterior line (12.9%), superior vena cava (8.6%), and vein of Marshall (8.6%). In patients without PV reconnection at repeat procedure, substrate mapping/individualized ablation is the preferred strategy (77.9%). No additional right atrial ablation beyond the CTI was reported. The majority of respondents (60.7%) consider rate control after ≥3 failed ablations.
conclusionReal-world strategies for repeat AF ablation show significant variability. 3D mapping and CF-guided RF ablation are commonly utilized. Re-PVI and substrate-based ablation are the predominant approaches. However, the optimal strategy beyond durable PVI remains to be further evaluated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.